Molecular signaling of therapeutic peptides in orthopaedic medicine — PI3K/Akt, mTOR, MAPK, TGF-β, AMPK pathways — VialBase Research
Growth hormone secretagogues (CJC-1295, ipamorelin) activate IGF-1 signaling
- Growth hormone secretagogues (CJC-1295, ipamorelin) activate IGF-1 signaling
- Peptides modulate PI3K/Akt, mTOR, MAPK, TGF-β, and AMPK pathways
- Satellite cell repair pathway is central to musculoskeletal recovery
- Preclinical studies are promising but clinical trials are lacking
Summary
Review integrating current mechanistic insights of therapeutic peptides with orthopaedic relevance. Maps molecular signaling networks including PI3K/Akt, mTOR, MAPK, TGF-β, and AMPK pathways. Groups peptides by function: wound-healing (BPC-157, TB-500, GHK-Cu), growth hormone secretagogues (ipamorelin, CJC-1295, tesamorelin, sermorelin, AOD-9604), recovery-enhancing (epithalon, DSIP, pinealon), and neuroactive (selank, semax, dihexa).
Key Findings
- CJC-1295 acts through GHRH receptor → cAMP/PKA → GH release → hepatic IGF-1 production
- IGF-1 activates PI3K/Akt pathway in satellite cells, promoting proliferation and differentiation
- This cascade is the primary mechanism for GH secretagogue-mediated musculoskeletal repair
- The review emphasizes safety considerations and future research directions
Relevance to CJC-1295
Provides the molecular pathway map for CJC-1295’s mechanism in tissue repair. The GHRH-R → cAMP → GH → IGF-1 → PI3K/Akt → satellite cell cascade is the core signaling pathway. Cross-references Ipamorelin, TB-500, BPC-157, GHK-Cu.
Citation
Orthopaedic Review. 2026. PMID: 41476424
See Also
- Parent compound: CJC-1295
- Ipamorelin
- TB-500
- BPC-157
- GHK-Cu
- Tesamorelin
- Sermorelin